AKT1 and Insulin resistance: Despite a lower inflammatory grade and tissue oxidative stress, two molecular pathways associated with the development of hepatic insulin resistance [47,48], GdCl3 treatment did not restore hepatic insulin sensitivity or alter fasting hepatic glucose production, as evidenced by unaltered AKT phosphorylation and pyruvate tolerance tests, respectively (Figure 5).